Atrás
76
Rango del Día
$33.40
$35.99
Rango de 52 Semanas
$24.10
$57.99
Volumen
2,137,919
Promedio 50D / 200D
$45.69
/
$39.68
Cierre Anterior
$35.57
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -7.8 | 0.4 |
| P/B | 3.7 | 2.9 |
| ROE % | -40.2 | 3.8 |
| Net Margin % | -6046.2 | 3.9 |
| Rev Growth 5Y % | 63.5 | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$94.71
+172.9%
Low: $67.00
High: $143.00
EPS Futuro
-$4.77
Ingresos Est.
62 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$4.93
$3.44 – $6.33
|
1.6 B | 1 |
| FY2029 |
$0.95
$0.67 – $1.22
|
930 M | 1 |
| FY2028 |
-$2.47
-$3.72 – -$0.99
|
420 M | 5 |
Puntos Clave
Revenue grew 63.46% annually over 5 years — strong growth
Debt/Equity of 0.05 — conservative balance sheet
Negative free cash flow of -383.68M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 577.25%
Capital intensive — 74.87% of revenue goes to capex
Crecimiento
Revenue Growth (5Y)
63.46%
Revenue (1Y)640.71%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-40.17%
ROIC-37.24%
Net Margin-6046.22%
Op. Margin-6714.77%
Seguridad
Debt / Equity
0.05
Current Ratio12.32
Interest Coverage0.00
Valoración
P/E Ratio
-7.81
P/B Ratio3.66
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 640.71% | Revenue Growth (3Y) | 38.48% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 63.46% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 7.70M | Net Income (TTM) | -465.32M |
| ROE | -40.17% | ROA | -40.98% |
| Gross Margin | 35.47% | Operating Margin | -6714.77% |
| Net Margin | -6046.22% | Free Cash Flow (TTM) | -383.68M |
| ROIC | -37.24% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.05 | Current Ratio | 12.32 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.81 | P/B Ratio | 3.66 |
| P/S Ratio | 472.23 | PEG Ratio | -0.28 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 3.63B | Enterprise Value | 3.58B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.70M | 1.04M | 4.01M | 4.74M | 1.08M |
| Net Income | -465.32M | -298.41M | -214.53M | -163.92M | -107.64M |
| EPS (Diluted) | -4.95 | -3.69 | -3.69 | -3.15 | -2.80 |
| Gross Profit | 2.73M | 1.04M | 4.01M | 4.74M | 1.08M |
| Operating Income | -516.77M | -338.85M | -222.61M | -167.88M | -107.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.14B | 1.43B | 635.35M | 352.18M | 351.02M |
| Total Liabilities | 143.41M | 109.79M | 96.25M | 35.85M | 19.07M |
| Shareholders' Equity | 992.08M | 1.32B | 539.11M | 316.33M | 331.94M |
| Total Debt | 48.54M | 51.72M | 51.73M | 3.08M | 3.07M |
| Cash & Equivalents | 101.54M | 264.55M | 54.90M | 32.67M | 200.70M |
| Current Assets | 1.05B | 1.38B | 574.15M | 345.18M | 344.72M |
| Current Liabilities | 85.07M | 59.68M | 43.94M | 27.72M | 16.00M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Heavy Grower
#14 of 75
Actividad Reciente
Entró
Capital Heavy Grower
Mar 24, 2026